|

humanized monoclonal anti-FGFR1 antibody OM-RCA-01 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Kidney Cancer Research Bureau1

Indications

  • Head Neck Cancer1
  • Renal Cell Carcinoma Metastatic1
  • Prostate Cancer Metastatic1
  • Breast Cancer, Metastatic1
  • Non-small Cell Lung Cancer Metastatic1

Other1 trial

A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.